Abstract
Patients who have survived an acute myocardial infarction, as well as those with atherosclerotic cardiovascular disease, established or unequivocally confirmed by imaging techniques, represent a very high-risk group. This group of patients requires more aggressive treatment of risk factors, regular controls, and monitoring of the effect of therapy. The article aimed to point out the historical importance of risk factors and modern models for assessing residual risk by reviewing the literature. Recognizing the residual risk provides orientation and motivation for more aggressive implementation of secondary preventive therapy on an individual level in daily work with patients and the possibility of reaching the target values recommended by European guidelines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
